To compare the prognostic value of stress echocardiography results in men and women with known and suspected coronary artery disease.
However, younger women have substantially higher mortality rates than men after myocardial infarction and coronary bypass surgery. 1 Several factors, although not completely understood, might account for the higher mortality rates in women. Women with myocardial infarction are older and have more comorbidity and risk factors, such as diabetes, hypertension, renal insufficiency, and congestive heart failure. 3 Selective underuse, underdiagnosis, and undertreatment of women with abnormal test results may explain the suboptimal diagnostic accuracy of noninvasive testing. 4, 5 Interest has grown in the use of stress echocardiography for evaluating coronary artery disease in women because of proved cost-effectiveness [6] [7] [8] and high diagnostic [9] [10] [11] [12] [13] and prognostic [14] [15] [16] [17] [18] [19] [20] [21] value, incremental to that of exercise electrocardiography. 17 The aim of this multicenter, observational study was to compare the prognostic value of stress echocardiography results in a large cohort of male and female patients with known or suspected coronary artery disease.
MATERIALS AND METHODS

Patients
From the prospective databases of 3 different Italian institutions (Lucca, Pisa, Milan), 8940 patients who underwent stress echocardiography between 1995 and 2006 were selected initially. Exclusion criteria were significant valvular or congenital heart disease, significant comorbidity reducing life expectancy to less than 1 year, and inadequate acoustic window. Of these patients, 203 (2%) were lost to follow-up. The remaining 8737 patients (5529 men and 3208 women) had complete follow-up information and formed the study population. Therefore, this is a retrospective analysis of a prospectively collected database. Indication to stress echocardiography was suspected coronary artery disease in 4880 subjects (56%) and risk stratification of known coronary artery disease in 3857 subjects (44%). Coronary artery disease was defined as recent or a history of acute coronary syndromes (ST-elevation myocardial infarction or non-ST-elevation myocardial infarction) or coronary revascularization and/or the presence of more than 1 angiographically documented coronary stenosis greater than 50%. The stressor used (523 exercise, 6227 dipyridamole, and 1987 dobutamine) was chosen on the basis of specific contraindications, local facilities, and physician's preference. Pharmacologic stress echocardiography was used when the exercise electrocardiography result was nondiagnostic or inconclusive. The choice of the pharmacologic stressor was made on the basis of potential relative contraindications of one over the other and on a gradient of safety (dipyridamole is safer than dobutamine). Stress echocardiography was performed on antianginal medical therapy in 3005 patients (34%) (␤-blockers in 1395 patients, calcium antagonists in 1179 patients, or nitrates in 1572 patients) and off therapy in 5732 patients (66%). Informed consent was obtained from all patients before testing, and the study protocol was approved by the institutional ethical committee. Stress echocardiography data were collected and analyzed by stress echocardiographers not involved in patient care. All investigators of contributing centers passed quality-control criteria for regional wall motion before entering the study as previously described. 22 Diabetes mellitus, 23 arterial hypertension, 24 and hypercholesterolemia 25 were defined according to standard definitions. All patients were followed up for a median of 25 months (first quartile 6 months, third quartile 58 months) with a minimum predefined follow-up time of 3 months.
Stress Protocol
Exercise stress echocardiography was conducted using a semi-supine bicycle ergometer with 25 W incremental loading every 2 minutes. Dipyridamole (up to 0.84 mg for 10 minutes with co-administration of atropine up to 1 mg or up to 0.84 mg for 6 minutes) and dobutamine (up to 40 mg/kg/min with co-administration of atropine up to 1 mg) stress echocardiography were performed according to well-established protocols.
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Echocardiographic Analysis
Echocardiographic images were semiquantitatively assessed using a 17-segment, 4-point scale model of the left ventricle. 26 A wall motion score index was derived by dividing the sum of individual segment scores by the number of interpretable segments. Ischemia was defined as stress-induced new or worsening of preexisting wall motion abnormality or biphasic response (ie, low-dose improvement followed by highdose deterioration). Necrotic pattern was akinetic or dyskinetic myocardium with no thickening during stress. A test was normal in case of no rest and stress wall motion abnormality.
Follow-up
Outcome was determined from patients' interviews at the outpatient clinic, hospital chart reviews, and telephone interviews with the patient, his/her close relative, or referring physician. Death and nonfatal myocardial infarction were registered as clinical events. Coronary revascularization (surgery or angioplasty) also was recorded. To avoid misclassification of the cause of death, 27 overall mortality was considered. Myocardial infarction was defined by typical symptoms, electrocardiographic, and cardiac enzyme changes. Follow-up data were analyzed for the prediction of hard events (death or nonfatal myocardial infarction).
Statistical Analysis
Continuous variables are expressed as mean Ϯ standard deviation. Differences between groups were compared using the Student t and chi-square test, as appropriate. Survival rates were estimated with Kaplan-Meier curves and compared by the log-rank test. Patients undergoing coronary revascularization were censored at the time of the proce-
CLINICAL SIGNIFICANCE
• There is no gender gap in the prognostic power of stratification of physical or pharmacologic stress echocardiography. The survival rate is comparable between men and women.
• Stress echocardiography is an equal opportunity approach for prognostic purposes in women.
• Women have a higher event rate than men in the presence of ischemia and known coronary artery disease.
dure. Only the first event was taken into account. Annual event rates were obtained from Kaplan-Meier estimates to take censoring of the data into account. The association of selected variables with outcome were assessed with the Cox's proportional hazard model using univariate and stepwise multivariate procedures. A significance of .05 was required for a variable to be included into the multivariate model, whereas 0.1 was the cutoff value for exclusion. Hazard ratios with the corresponding 95% confidence interval were estimated. Statistical significance was set at P less than .05. Moreover, clinical findings, resting wall motion score index, and ischemia at stress echocardiography were sequentially included in the model. Global chi-square value of the model was calculated from the log-likelihood ratio; a significant increase after the addition of further variables indicated incremental prognostic value. To evaluate the ability of stress echocardiography to classify risk, we plotted receiver operating characteristic (ROC) curves for the clinical variables included in the analysis. The C statistics, a measure of the area under the ROC curve, was calculated with and without the stress echocardiography positivity. We also evaluated the ability of stress echocardiography to reclassify risk across categories with the use of the approach, as suggested by Pencina et al. 28 The Statistical Package for the Social Sciences (release 13.0, SPSS Inc, Chicago, Ill) was used for analysis.
RESULTS
Inducible ischemia was assessed in 2760 patients (32%), 2000 of whom were men and 760 of whom were women (36% vs 24%; P Ͻ .0001). Wall motion score index at peak of ischemia was similar in men and women (1.54 Ϯ 0.33 vs 1.53 Ϯ 0.34, P ϭ .53). A necrotic pattern was observed in 1668 men and 672 women (30% vs 21%, P Ͻ .0001); resting wall motion score index was 1.56 Ϯ 0.38 in men and 1.53 Ϯ 0.36 in women (P ϭ .12). Test results were normal in 1861 men and 1776 women (34% vs 55%, P Ͻ .0001). Table 1 shows the main clinical and echocardiographic findings for male and female patients with known and suspected coronary artery disease.
Outcomes
During a median follow-up of 25 months (first quartile 6 months, third quartile 58 months), 1218 patients (14%) had a cardiac event (693 deaths and 525 nonfatal myocardial infarctions). A total of 533 events occurred in the 2968 men and 172 occurred in the 889 women with known coronary artery disease (18% vs 19%; P ϭ .63). A total of 319 events occurred in 2561 men and 194 events occurred in 2319 women with suspected coronary artery disease (12% vs 8%; P Ͻ .0001). Data presented are mean value Ϯ standard deviation or number (%) of patients. CAD ϭ coronary artery disease; CABG ϭ coronary artery bypass grafting; PCI ϭ percutaneous coronary intervention; WMA ϭ wall motion abnormality; WMSI ϭ wall motion score index.
According to the physician's judgment, 2263 patients (26%) (1731 men [31%] and 532 women [17%]; P Ͻ .0001) underwent coronary revascularization (796 underwent surgery and 1467 underwent angioplasty) after a median of 45 days (first quartile 7 days, third quartile 212 days) from the index stress echocardiography. Figure 1 shows the rates of revascularization in men and women with known and suspected coronary artery disease according to the presence or absence of inducible ischemia. In the group with known coronary artery disease, revascularization rate was higher (P Ͻ .0001) in men than in women without ischemia. In the group with suspected coronary artery disease, the revascularization rate was higher (P Ͻ .0001) in men regardless of the stress echocardiography result.
Outcome Prediction
The annual hard event rate was 5.8% in men and 7.0% in women with coronary artery disease (P ϭ .08). The annual hard event rate was 3.6% in men and 2.4% in women with suspected coronary artery disease (P Ͻ .0001). Figures 2  and 3 show the incremental model of prediction in known and suspected coronary artery disease separated on gender.
The univariate and multivariable prognostic indicators in patients with known and suspected coronary artery disease are reported in Table 2 . In the subset of women with known coronary artery disease and a positive test result for myocardial ischemia, the event rate was higher than in men (P ϭ .01). No gender difference was observed in the subset of patients with a negative test result for inducible myocardial ischemia P ϭ .30) (Figure 4 ). On analysis of data (Figures 5 and 6 ) according to prognostically important clinical covariates, such as age and diabetes mellitus, only nondiabetic women had a higher risk than men with a history of known coronary artery disease and inducible ischemia (P ϭ .007) (Figure 6 ). The annual event rate in a normal test was 2.6% in men and 1.6% in women (P Ͻ .0001). In the nonischemic group, the annual event rate was worse in men aged less than 65 years (P Ͻ .0001) and more than 65 years (P ϭ .04) (Figure 5 ), as well as in those with (P ϭ .03) or without P Ͻ .0001) diabetes ( Figure 6 ). We constructed ROC curves for the model incorporating established risk factors with and without inclusion of the stress echocardiography result using the incidence of events as the outcome. The C statistic (area under the ROC curve) for hard events was 0.66 for the risk model that included the stress echocardiography test result (Figure 7 ). When we used the net reclassification index 28 to account for the correct movement in categories (higher risk for subjects in whom events occurred and lower risk for subjects free of events), there was a significant improvement in risk classification according to the model that incorporated the stress echocardiography test result compared with the model that included conventional clinical risk factors or the model that included conventional risk factors and rest wall motion score index (Table 3 ). 
DISCUSSION
Although coronary artery disease generally becomes clinically evident at least 10 years later in women than in men, once it is manifest more adverse outcomes have been reported for women. [29] [30] [31] Indeed, 49% of overall mortality due to coronary artery disease is observed in the female population. 1 Thus, recognizing coronary artery disease in women and identifying those at increased risk of future cardiac events is an emerging point in contemporary cardiology. Unfortunately, diagnostic workup in female patients may be limited by clinical misperception of a lower pretest probability of coronary artery disease by the physician and by suboptimal diagnostic accuracy reported with various noninvasive cardiac tests. 5, 6 Stress echocardiography is a recognized equal opportunity approach, providing useful results for both diagnostic [9] [10] [11] [12] [13] and prognostic [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] purposes in women. A recent report from the Agency for Health-Related Quality revealed that exercise echocardiography is highly accurate at detecting coronary artery disease in women with a sensitivity of 84% and a specificity of 76%. 32 In addition, more recent evidence also supports the use of stress echocardiography for the estimation of prognosis in women. [19] [20] [21] In a recent report in 4234 women, the extent of ischemic wall motion abnormalities was highly predictive of cardiac death. 20 For women undergoing exercise echocardiography, 5-year survivals were 99.4%, 97.6%, and 95% for those with no, single, and multivessel ischemia, respectively. Significantly higher cardiac death rates were noted for those women undergoing dobutamine stress echocardiography with annualized death rates ranging from 1% to 3% for 0-to 3-vessel ischemia. 20 From a clinical standpoint, to know whether these results also apply to populations of male and female patients with similar clinical characteristics would allow optimized patient management. Therefore, in this study on 8737 patients, we compared the prognostic value of stress echocardiography results in men and women in populations selected on the basis of history of coronary Figure 3 In patients with suspected coronary artery disease, the clinical model had a global chi-square of 129.9 (P Ͻ .0001) in men and 70.6 (P Ͻ .0001) in women; after the addition of resting wall motion score index and ischemia at stress echocardiography, it increased by 8% (140.9; P Ͻ .0001) and 33% (187.1; P Ͻ .0001) in men and by 39% (98.2; P Ͻ .0001) and 69% (166.4; P Ͻ .0001) in women. WMSI ϭ wall motion score index. CAD ϭ coronary artery disease; CABG ϭ coronary artery bypass grafting; PCI ϭ percutaneous coronary intervention; WMA ϭ wall motion abnormality; WMSI ϭ wall motion score index; HR ϭ hazard ratio; CI ϭ confidence interval.
artery disease and prognostically important clinical parameters. We found age, diabetes mellitus, and ischemia at stress echocardiography to be strong and independent prognostic indicators in patients with known and suspected coronary artery disease. Moreover, inducible ischemia provided incremental value over clinical variables and resting left ventricular function for predicting death or myocardial infarction in both sexes regardless of history of coronary artery disease. Nevertheless, the prognostic information provided by both ischemic and nonischemic test results showed gender-related differences in different clinical settings. In particular, women had a similar and perhaps greater risk for adverse outcome than men when the diagnosis of coronary artery disease was documented or very likely. In fact, nondiabetic coronary artery disease women with ischemia fared worse than their male counterparts. Conversely, women with suspected coronary artery disease and no ischemia had a better prognosis than men, regardless of age and history of diabetes. In keeping with previous results, 33 in our study women with coronary artery disease were more likely to be older and to have a history of diabetes mellitus, hypertension, and hypercholesterolemia, and less likely to be smokers than men. In addition, they had a better resting left ventricular function. Whether and to what extent these differences between genders may have contributed to prognosis is not clear. Notably, age and diabetes were not associated with different risk in men and women with and without ischemia. In the present study, women were less likely revascularized than men regardless of history of coronary artery disease. This is consistent with previous studies showing that women undergo cardiac catheterization and revascularization procedures less often than men in the case of manifest coronary artery disease. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] In a recent study, 29 less aggressive treatment strategy in women Figure 4 Hard event rate for women and men with known and suspected coronary artery disease separated on the basis of presence (ϩ) and absence (Ϫ) of ischemia at stress echocardiography. Number of patients per year is shown. CAD ϭ coronary artery disease; SE ϭ stress echocardiography.
Figure 5
Annual hard event rate for women and men with known and suspected coronary artery disease according to the presence (ϩ) and absence (Ϫ) of ischemia at stress echocardiography. The data were separately analyzed in patients aged less than 65 years and more than 65 years. CAD ϭ coronary artery disease; SE ϭ stress echocardiography.
with stable angina was associated with a 2-fold greater risk of death or nonfatal myocardial infarction during the 1-year follow-up period. Because prognosis is at least comparable in men and women with ischemia and in those with coronary artery disease and no ischemia, sex referral bias is not justified and availability for major procedures should be similar for both genders. The protective effect by revascularization has been documented in men and women.
34
STUDY LIMITATIONS
Dipyridamole was the most frequently used stressor in the echocardiography laboratories that were involved in the study. Although less used outside Europe, dipyridamole is as sensitive and accurate 35, 36 and exerts the same prognostic power [37] [38] [39] [40] as dobutamine when state of the art protocols are used as recommended by the European Association of Echocardiography. 26 Because of the long recruitment period, the outcome based on stress test results may have been potentially influenced by the evolution of methodology, technology, and expertise and advances in medical and interventional treatments. In this study, there was no central reading. Stress echocardiography was interpreted in the peripheral centers and entered directly in the database. This system allowed substantial sparing of human and technologic resources, but it also was the logical prerequisite for a large-scale study designed to represent the realistic performance of the test rather than the results of a single laboratory, or even a single person, working in a highly dedicated echocardiography laboratory. Because the assessment of the echocardiograms was qualitative and subjective, variability in reading the echocardiograms might have modulated the results of individual centers. 26 However, all our readers in individual centers had lengthy experience in echocardiography and passed the quality control in stress echocardiography reading as previously described. 22 Our study design was observational, not randomized, and the analysis was retrospective, although the data were acquired in a prospective fashion and entered into the databank at the time of initial assessment. The test results available to the referring physicians may have influenced the clinical management of Figure 6 Annual hard event rate for women and men with known and suspected coronary artery disease, according to the presence (ϩ) and absence (Ϫ) of ischemia at stress echocardiography. The data were separately analyzed in nondiabetic and diabetic patients. CAD ϭ coronary artery disease; SE ϭ stress echocardiography. the patients, especially regarding coronary revascularization, but this may have only decreased the prognostic power of the test, because patients were censored at the time of the procedure. 
